Access cutting-edge stroke treatment through this clinical trial at a research site in Berkeley. Study-provided care at no cost to qualified participants.
Access stroke specialists in Berkeley at no cost
This study follows strict safety protocols and ethical guidelines
All study-related stroke treatment provided free
The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.
Sponsor: Janssen Research & Development, LLC
Check if you qualify for this stroke clinical trial in Berkeley, CA
If you're searching for stroke treatment options in Berkeley, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Berkeley research site is actively enrolling participants for this clinical trial. You'll receive care from experienced stroke specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.